Emilia Gabriela Sardo
Member of the Cancer Profiling Research Line
Email: emiliagabriela.sardo@uvic.cat
ORCID: 0000-0002-1764-0528
Scientific Profile: URECERCA
I am a Medical Oncologist who graduated in Medicine from the Universidad Católica de Córdoba. After completing my residency training, I pursued a fellowship at the Hospital Universitario Vall d’Hebron and subsequently undertook an observership at the Università degli Studi della Campania Luigi Vanvitelli in Naples, Italy.
I currently work as a Consultant Medical Oncologist at the Hospital Universitari de Vic, where I am involved in clinical work and clinical research, alongside teaching activities. My clinical practice focuses on breast cancer and gynaecological cancers, allowing me to integrate patient care with research in a direct and meaningful way. I am actively involved in the training of medical residents and in undergraduate teaching at the Universitat de Vic – Central University of Catalonia, where I serve as Associate Professor of Oncology.
Since September 2022, I am pursuing a PhD in Medicine and Biomedical Sciences at the Universitat de Vic – Central University of Catalonia, supported by an Industrial Doctorate fellowship. My research focuses on translational research in gynaecological cancers, with a particular emphasis on endometrial cancer. In parallel, I am also enrolled in a postgraduate Expert Programme in gynaecological cancers at the Universitat de Girona, further strengthening my specialised training in this field.
My last happenings:
TR2Lab was present at the Spanish Society of Geriatric and Gerontological Nursing Congress
Recently, Dr. Marta Casals, member of TR2Lab, participated in the Congress of the Spanish Society of Geriatric and Gerontological Nursing (SEEGG), a leading scientific meeting for professionals dedicated to the care of older adults. As part of the scientific programme, Dr. Marta Casals presented an oral communication entitled “Translation, Cross-Cultural Adaptation and Validation of the Wound-QoL-17 Scale into Catalan.” The study aimed to provide a validated instrument for assessing the impact of chronic wounds on the quality of life of Catalan-speaking patients. The presentation described the translation and cultural adaptation process of the questionnaire, as well as the psychometric validation [...]
Molecular autopsy identifies the NaV1.5 p.Leu96Pro variant causing sodium current loss-of-function in unexplained sudden cardiac death
Authors: Albert Rigat Pujolasa, Rebecca Martínez-Moreno, David Carreras, Yajaira Alvarado-Cervantes, Elisabet Selga, Ramon Brugada, Guillermo J. Pérez, Fabiana S. Scornik Forensic Science International: Genetics, 86 (2027) 103587 DOI: 10.1016/j.fsigen.2026.103587 Read More Abstract Molecular autopsy can identify candidate variants in unexplained sudden cardiac death (SUD), but functional evidence is often required to support pathogenic interpretation and family risk assessment. Here, we investigated the functional consequences of the SCN5A c.287 T >C (NaV1.5_p.Leu96Pro) variant, identified in a 29-year-old man who died of SUD. Cascade screening identified additional relatives carrying the variant, with variable clinical expression. Sodium current (INa) was [...]
TR2Lab Joins Global Experts at the ERS International Congress 2026
Dr. Renata Da Palma, member of TR2Lab, participated in the ERS International Congress 2026 held in Barcelona, one of the world's largest and most influential meetings in respiratory medicine and science. During the event, she presented TR2Lab’s research on the anti-inflammatory effects of photobiomodulation therapy in an experimental model of asthma-COPD overlap. The congress brought together researchers, clinicians, and healthcare professionals from across the globe to share the latest advances in respiratory health, fostering scientific exchange and international collaboration. Scientific meetings such as ERS play an essential role in advancing research by facilitating knowledge sharing, promoting innovation, and creating new [...]
